Anal Cancer pT2 TNM Finding v6 and v7

description: Anal cancer with tumor size more than 2 centimeters, but 5 centimeters or less, in greatest dimension. (from AJCC 6th and 7th Eds.)


name: Anal Cancer Pathologic Primary Tumor TNM Finding v6

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A pathologic finding about one or more characteristics of anal cancer, following the rules of the TNM AJCC v6 classification system as they pertain to staging of the primary tumor.


Anal Cancer pT3 TNM Finding v6 and v7

description: Anal cancer with tumor size more than 5 centimeters in greatest dimension. (from AJCC 6th and 7th Eds.)


Anal Cancer pT4 TNM Finding v6 and v7

description: Anal cancer with tumor of any size that invades adjacent organ(s); e.g. vagina, urethra, bladder. Direct invasion of the rectal wall, perirectal skin, subcutaneous tissue, or the sphincter muscle(s) is not classified as T4. (from AJCC 6th and 7th Eds.)


Anal Cancer pTis TNM Finding v6 and v7

description: Anal cancer in situ. (from AJCC 6th and 7th Eds.)


Anal Cancer pT0 TNM Finding v6 and v7

description: Anal cancer with no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)


Anal Cancer pT1 TNM Finding v6 and v7

description: Anal cancer with tumor size 2 centimeters or less in greatest dimension. (from AJCC 6th and 7th Eds.)


Anal Cancer pTX TNM Finding v6 and v7

description: Anal cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)


HENEICOSANOIC ACID

A long-chain fatty acid that is henicosane in which one of the methyl groups has been oxidised to give the corresponding carboxylic acid.


saturated fatty acid

Any fatty acid containing no carbon to carbon multiple bonds. Known to produce adverse biological effects when ingested to excess.


HEXANOATE

A C6, straight-chain saturated fatty acid.


isobutyric acid

A branched fatty acid comprising propanoic acid carrying a methyl branch at C-2.


20-methylhenicosanoic acid

A methyl-branched fatty acid that is  henicosanoic acid substituted by a methyl group at position 20.


isocaproic acid

A methyl-branched fatty acid that is pentanoic acid with a methyl group substituent at position 4. It is a metabolite of 20 alpha-hydroxycholesterol


22-methyltricosanoic acid

A methyl-branched fatty acid that is  tricosanoic acid substituted by a methyl group at position 22.


C22-C26 saturated fatty acid

Any saturated fatty acid containing 22-26 carbons.


DOTRIACONTANOIC ACID

A straight-chain saturated fatty acid that is dotriacontane in which one of the methyl groups has been oxidised to the corresponding carboxylic acid.


24-methylhexacosanoic acid

A  methyl-branched fatty acid that is  cerotic acid substituted by a methyl group at position 24.


TRICOSANOIC ACID

A very long-chain fatty acid that is tricosane in which one of the methyl groups has been oxidised to the corresponding carboxylic acid.


20-hydroxyhenicosanoic acid

An (omega-1)-hydroxy fatty acid that is henicosanoic acid in which one of the hydrogens at position 20 has been replaced by a hydroxy group.


DIMEBUTIC ACID

A branched-chain fatty acid and metabolite of the lactone prodrug simvastatin, whose sodium salt is potentially useful for the treatment of thalassaemias and haemoglobinopathies.


pristanic acid

A branched, long-chain saturated fatty acid composed of pentadecanoic acid having methyl substituents at the 2-, 6-, 10- and 14-positions.


7-methyloctanoic acid

A branched-chain saturated fatty acid consisting of octanoic acid carrying a 7-methyl group.


2,3-dimethylbutyric acid

A branched C4 short-chain fatty acid carrying two methyl substituents at positions 2 and 3. The methyl group at the 2-position confers chirality, hence the compound has two possible enantiomers.


LEVULINIC ACID

An oxopentanoic acid with the oxo group in the 4-position.


2-methylhexadecanoic acid

A methyl-branched fatty acid that is hexadecanoic (palmitic) acid bearing a methyl substituent at position 2.


(20R)-20-hydroxyhenicosanoic acid

A 20-hydroxyhenicosanoic acid that has R configuration.


A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at posiitons 1 and 2 are specified respectively as hexadecanoyl and methyl.


18-methylicosanoic acid

A methyl-branched fatty acid that is  arachidic acid substituted by a methyl group at position 18.


3-methylvaleric acid

A methyl-branched fatty acid that is pentanoic acid which carries a methyl group at position 3.


15-hydroxypentadecanoic acid

An omega-hydroxy-long-chain fatty acid that is pentadecanoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


28-methylnonacosanoic acid

A  methyl-branched fatty acid that is nonacosanoic acid substituted by a methyl group at position 28.


3-METHYLBUTANOIC ACID

A C5, branched-chain saturated fatty acid.


HEXACOSANOIC ACID

A 26-carbon, straight-chain, saturated fatty acid.


isotridecanoic acid

A branched-chain saturated fatty acid comprising dodecanoic (lauric) acid substituted at position 11 by a methyl group.


isoheptadecanoic acid

A branched-chain saturated fatty acid comprising hexadecanoic (palmitic) acid substituted at position 15 by a methyl group.


19-hydroxynonadecanoic acid

An omega-hydroxy-long-chain fatty acid that is nonadecanoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


docosanoic acid

A straight-chain, C22, long-chain saturated fatty acid.


branched-chain saturated fatty acid

Any saturated fatty acid with a carbon side-chain or isopropyl termination.


16-methyloctadecanoic acid

A methyl-branched fatty acid that is octadecanoic acid substituted by a methyl group at position 16.


10,13-dimethyltetradecanoic acid

A branched-chain saturated fatty acid comprising tetradecanoic acid carrying a methyl substituent at positions 10 and 13. It is a marine metabolite isolated from the Caribbean Sponges Calyx podatypa and Agelas dispar.


24-methylpentacosanoic acid

A methyl-branched fatty acid that is pentacosanoic acid substituted by a methyl group at position 24.


N-OCTACOSANOIC ACID

A straight-chain saturated fatty acid that is octacosane in which one of the terminal methyl groups has been oxidised to the corresponding carboxy group.


10-methyldodecanoic acid

A methyl-branched fatty acid that is dodecanoic acid (lauric acid) substituted by a methyl group at position 10.


22-methyltetracosanoic acid

A methyl-branched fatty acid that is tetracosanoic acid (lignoceric acid) substituted by a methyl group at position 22.


20-hydroxyicosanoic acid

An omega-hydroxy-long-chain fatty acid that is icosanoic acid (arachidonic acid) in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


16-methylheptadecanoic acid

A methyl-branched fatty acid that is heptadecanoic acid (margaric acid) substituted by a methyl group at position 16.


12-methyltetradecanoic acid

A branched-chain saturated fatty acid comprising tetradecanoic acid carrying a 12-methyl substituent.


12-methyloctadecanoic acid

A methyl-branched fatty acid that is octadecanoic (stearic) acid bearing a methyl substituent at position 12.


(2S)-2-methylheptadecanoic acid

A methyl-branched fatty acid that is heptadecanoic (margaric) acid bearing a methyl substituent at position 2 (the S-enantiomer).


triacontanoic acid

A C30, very long straight-chain, saturated fatty acid.


3-methylundecanoic acid

A methyl-branched fatty acid that is undecanoic acid bearing a methyl substituent at position 3.


palmitic acid-d31

A C16 straight-chain saturated fatty acid where the aliphatic hydrogens have been replaced by deuterium atoms.


2-ethylhydracrylic acid

A branched-chain saturated fatty acid that is butanoic acid substituted by a hydroxymethyl group at position 2. It is a metabolite derived from the isoleucine metabolism.


(R)-2,3-dimethylbutyric acid

The (R)-enantiomer of 2,3-butyric acid.


3,13,19-trimethyltricosanoic acid

A methyl-branched fatty acid that is tricosanoic acid substituted by a methyl group at positions 3, 13 and 19.


ARACHIDIC ACID

A C20 striaght-chain saturated fatty acid which forms a minor constituent of peanut (L. arachis) and corn oils. Used as an organic thin film in the production of liquid crystals for a wide variety of technical applications.


PIVALATE

A branched, short-chain fatty acid composed of propanoic acid having two methyl substituents at the 2-position.


21-hydroxyhenicosanoic acid

An omega-hydroxy-long-chain fatty acid that is henicosanoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


LIGNOCERIC ACID

A C24 straight-chain saturated fatty acid.


omega-hydroxy-15-methylpalmitic acid

A hydroxy fatty acid obtained by hydroxylation of one of the two terminal methyl groups of isoheptadecanoic acid.


PENTADECANOIC ACID

A straight-chain saturated fatty acid containing fifteen-carbon atoms.


pentanoic acid

A straight-chain saturated fatty acid containing five carbon atoms.


13-methylpentadecanoic acid

A methyl-branched fatty acid that is pentadecanoic acid substituted by a methyl group at position 13.


12-methylpentadecanoic acid

A methyl-branched fatty acid that is pentadecanoic acid substituted by a methyl group at position 12.


14-methylpentadecanoic acid

A methyl-branched fatty acid that is pentadecanoic acid substituted by a methyl group at position 14. It is a biomarker for rheumatoid arthritis.


2-methylbutyric acid

A methylbutyric acid comprising a butyric acid core carrying a 2-methyl substituent. Produced from amino acid leucine during nutrient starvation in bacteria.


18-methylnonadecanoic acid

A methyl-branched fatty acid that is nonadecanoic acid substituted by a methyl group at position 18.


(R)-2-methylbutyric acid

The (R)-enantiomer of 2-methylbutanoic acid.


13-hydroxytridecanoic acid

An omega-hydroxy-long-chain fatty acid that is tridecanoic acid in which one of the hydrogens of the terminal methyl group is replaced by a hydroxy group.


10-methylundecanoic acid

A methyl-branched fatty acid that is  undecanoic acid substituted by a methyl group at position 10.


prostanoic acid

A carbocyclic fatty acid composed of heptanoic acid having a (1S,2S)-2-octylcyclopentyl substituent at position 7.


isomyristic acid

A branched-chain saturated fatty acid consisting of tridecanoic acid carrying a 12-methyl group.


17-methyloctadecanoic acid

A branched-chain saturated fatty acid that is octadecanoic (stearic) acid carrying a methyl substituent at position 17.


10-methyltetradecanoic acid

A branched-chain saturated fatty acid that is tetradecanoic acid in which one of the hydrogens at psoition 10 has been replaced by a methyl group. It is one of a number of methyl-branched fatty acids that have been identified as constituents of sheep perinephric fat.


19-hydroxyicosanoic acid

An (omega-1)-hydroxy fatty acid that is icosanoic acid (arachidic acid) in which a hydrogen at position 19 has been replaced by a hydroxy group.


14-methylhexadecanoic acid

A methyl-branched fatty acid that is hexadecanoic acid (palmitic acid) substituted by a methyl group at position 14.


isopentadecanoic acid

A branched-chain saturated fatty acid comprising tetradecanoic (myristic) acid substituted at position 13 by a methyl group.


26-methylheptacosanoic acid

A methyl-branched fatty acid that is heptacosanoic acid substituted by a methyl group at position 26.


methylbutyric acid

A methyl-branched fatty acid comprising a butyric acid core carrying a single methyl substituent.


20-methyldocosanoic acid

A methyl-branched fatty acid that is docosanoic acid (behenic acid) substituted by a methyl group at position 20.


NONADECANOIC ACID

A C19 straight-chain fatty acid of plant or bacterial origin. An intermediate in the biodegradation of n-icosane, it has been shown to inhibit cancer growth.


tetradecanoic-d27 acid

A C14 straight-chain saturated fatty acid where the aliphatic hydrogens have been replaced by deuterium atoms.


(2R,6S,10S)-2,6,10,14-pristanic acid

The (2R,6S,10S)-diastereomer of pristanic acid.


omega-hydroxyphytanic acid

A hydroxy fatty acid obtained by hydroxylation of one of the two terminal methyl groups of phytanic acid.


(+)-pentacycloanammoxic acid

A carbocyclic fatty acid consisting of octanoic acid which is terminally substituted by five fused cyclobutane-rings ([5]-ladderane). Ladderane fatty acids can be found in anammox bacteria.


(S)-2,3-dimethylbutyric acid

The (S)-enantiomer of 2,3-dimethylbutyric acid.


10-hydroxycapric acid

A 10-carbon, omega-hydroxy fatty acid, shown to be the preferred hydroxylation product (together with the 9-OH isomer) of capric acid in biosystems, and used as a standard in lipid assays; reported to have cytotoxic effects.


tetratriacontanoic acid

A straight-chain saturated fatty acid that is tetratriacontane in which one of the methyl groups has been oxidised to the corresponding carboxylic acid.


28-methyltriacontanoic acid

A methyl-branched fatty acid that is triacontanoic acid (melissic acid) substituted by a methyl group at position 28.


(S)-2-methylbutyric acid

The (S)-enantiomer of 2-methylbutanoic acid.


myristic acid

A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat.


HEPTADECANOIC ACID

A C17 saturated fatty acid and trace component of fats in ruminants.


straight-chain saturated fatty acid

Any saturated fatty acid lacking a side-chain.


decanoic acid

A C10, straight-chain saturated fatty acid.


2-methylvaleric acid

A methyl-branched fatty acid that is pentanoic acid which carries a methyl group at position 2.


T-BUTYLACETIC ACID

A dimethylbutyric acid in which both methyl substituents are at C3; used as an intermediate in the synthesis of medicines and agricultural chemicals.


dimethylbutyric acid

Any compound comprising a butyric acid skeleton carrying two methyl components.


C20-C26 saturated fatty acid

Any saturated fatty acid containing 20-26 carbons.


2-methyloctadecanoic acid

A methyl-branched fatty acid that is octadecanoic (stearic) acid bearing a methyl substituent at position 2.


heptacosanoic acid

A C27, very long straight-chain, saturated fatty acid.


26-methyloctacosanoic acid

A methyl-branched fatty acid that is octacosanoic acid (montanic acid) substituted by a methyl group at position 26.


tridecanoic-d25 acid

A C13 straight-chain saturated fatty acid where the aliphatic hydrogens have been replaced by deuterium atoms.


name: pituitary-specific positive transcription factor 1 isoform 1 (mouse)

description: A pituitary-specific positive transcription factor 1 isoform 1 that is encoded in the genome of mouse.


name: PIT1_MOUSE Pituitary-specific positive transcription factor 1 (sprot)

description: A pituitary-specific positive transcription factor 1 that is encoded in the genome of mouse.


name: pituitary-specific positive transcription factor 1 isoform m2 (mouse)

description: A pituitary-specific positive transcription factor 1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q00286-2.


name: pituitary-specific positive transcription factor 1 isoform 3 (mouse)

description: A pituitary-specific positive transcription factor 1 isoform 2 that is encoded in the genome of mouse.


name: H1BP3_MOUSE HCLS1-binding protein 3 (sprot)

description: An HCLS1-binding protein 3 that is encoded in the genome of mouse.


plectin isoform mPLEC-1F (mouse)

A plectin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9QXS1-13.


variable charge X-linked protein 1

A protein that is a translation product of the human VCX gene or a 1:1 ortholog thereof.


name: VCX1_HUMAN Variable charge X-linked protein 1 (sprot)

description: A variable charge X-linked protein 1 that is encoded in the genome of human.


Recurrent Dedifferentiated Chordoma

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: The reemergence of dedifferentiated chordoma after a period of remission.


Recurrent Chordoma

description: The reemergence of chordoma after a period of remission.


Locally Recurrent Chordoma

description: The reemergence of chordoma after a period of remission, at or adjacent to the site of the original tumor.


disks large homolog 4 isoform 3 (mouse)

A disks large homolog 4 isoform 3 that is encoded in the genome of mouse.


name: DLG4_MOUSE Disks large homolog 4 (sprot)

description: A disks large homolog 4 that is encoded in the genome of mouse.


disks large homolog 4 isoform 1 (mouse)

A disks large homolog 4 isoform 1 that is encoded in the genome of mouse.


disks large homolog 4 isoform 2 (mouse)

A disks large homolog 4 isoform 2 that is encoded in the genome of mouse.


name: NEP_I68A0 Nuclear export protein (sprot)

description: An influenzavirus nuclear export protein that is encoded in the genome of the H3N2 strain A/Aichi/2/1968.


name: Ras and Rab interactor-like protein isoform h2 (human)

description: A Ras and Rab interactor-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZS11-2.


name: RINL_HUMAN Ras and Rab interactor-like protein (sprot)

description: A Ras and Rab interactor-like protein that is encoded in the genome of human.


name: Ras and Rab interactor-like protein methylated 1 (human)

description: A Ras and Rab interactor-like protein (human) that has been methylated on the residue at the position equivalent to Cys-421 of the amino acid sequence represented by UniProtKB:Q6ZS11-1. Example: UniProtKB:Q6ZS11-1, Cys-421, MOD:00660.


name: Ras and Rab interactor-like protein isoform h1 (human)

description: A Ras and Rab interactor-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZS11-1.


name: polynucleotide 5'-hydroxyl-kinase NOL9 isoform m1 (mouse)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3TZX8-1.


polynucleotide 5'-hydroxyl-kinase NOL9

A protein that is a translation product of the human NOL9 gene or a 1:1 ortholog thereof.


name: NOL9_DANRE Polynucleotide 5'-hydroxyl-kinase NOL9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of zebrafish.


name: polynucleotide 5'-hydroxyl-kinase NOL9 isoform 2 (Arabidopsis thaliana)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8VYP6-2.


name: polynucleotide 5'-hydroxyl-kinase NOL9 isoform m2 (mouse)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3TZX8-2.


name: NOL9_DROME Polynucleotide 5'-hydroxyl-kinase NOL9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of fruit fly.


name: polynucleotide 5'-hydroxyl-kinase NOL9 isoform m3 (mouse)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3TZX8-3.


name: polynucleotide 5'-hydroxyl-kinase NOL9 methylated 1 (human)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (human) that has been methylated on the residue at the position equivalent to Cys-347 of the amino acid sequence represented by UniProtKB:Q5SY16. UniProtKB:Q5SY16, Cys-347, MOD:00660.


name: NOL9_ARATH Polynucleotide 5'-hydroxyl-kinase NOL9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of Arabidopsis thaliana.


name: polynucleotide 5'-hydroxyl-kinase NOL9 cysteinylated 1 (human)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (human) that has been cysteinylated on the residue at the position equivalent to Cys-144 of the amino acid sequence represented by UniProtKB:Q5SY16. UniProtKB:Q5SY16, Cys-144, MOD:00765.


name: polynucleotide 5'-hydroxyl-kinase NOL9 methylated 2 (human)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (human) that has been methylated on the residue at the position equivalent to Cys-140 of the amino acid sequence represented by UniProtKB:Q5SY16. UniProtKB:Q5SY16, Cys-140, MOD:00660.


name: NOL9_MOUSE Polynucleotide 5'-hydroxyl-kinase NOL9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of mouse.


name: polynucleotide 5'-hydroxyl-kinase nol-9 isoform a (worm)

description: A polynucleotide 5'-hydroxyl-kinase nol-9 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9U3B6-1.


name: polynucleotide 5'-hydroxyl-kinase NOL9 isoform 1 (Arabidopsis thaliana)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8VYP6-1.


name: polynucleotide 5'-hydroxyl-kinase NOL9, initiator methionine removed form

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that has had the initiator methionine removed.


name: polynucleotide 5'-hydroxyl-kinase NOL9, initiator methionine removed form (human)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (human) that has had the initiator methionine removed. UniProtKB:Q5SY16, 2-702.


name: NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of human.


name: polynucleotide 5'-hydroxyl-kinase nol-9 isoform b (worm)

description: A polynucleotide 5'-hydroxyl-kinase nol-9 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9U3B6-2.


name: polynucleotide 5'-hydroxyl-kinase NOL9 cysteinylated 2 (human)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 (human) that has been cysteinylated on the residue at the position equivalent to Cys-140 of the amino acid sequence represented by UniProtKB:Q5SY16. UniProtKB:Q5SY16, Cys-140, MOD:00765.


name: NOL9_DICDI Polynucleotide 5'-hydroxyl-kinase nol9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of Dictyostelium discoideum.


name: NOL9_CAEEL Polynucleotide 5'-hydroxyl-kinase nol-9 (sprot)

description: A polynucleotide 5'-hydroxyl-kinase NOL9 that is encoded in the genome of worm.


name: P2C71_ARATH Probable protein phosphatase 2C 71 (sprot)

description: A protein that is a translation product of the At5g24940 gene in Arabidopsis thaliana.


name: myosin type-2 heavy chain 1 unmodified form

description: A myosin type-2 heavy chain 1 that has not been subjected to any co- or post-translational residue modification or peptide bond cleavage.


myosin type-2 heavy chain 1

A protein that is a translation product of the Schizosaccharomyces pombe 972h- myo2 gene or a 1:1 ortholog thereof.


name: myosin heavy chain, non-muscle isoform 3 (fruit fly)

description: A myosin heavy chain, non-muscle (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99323-3.


name: myosin type-2 heavy chain 1 phosphorylated 1 (Schizosaccharomyces pombe)

description: A myosin type-2 heavy chain 1 phosphorylated 1 in Schizosaccharomyces pombe. Example: UniProtKB:Q9USI6, Ser-1444, MOD:00046.


name: myosin heavy chain, non-muscle isoform 2 (fruit fly)

description: A myosin heavy chain, non-muscle (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99323-2.


MYS2_DICDI Myosin-2 heavy chain (sprot)

A myosin type-2 heavy chain 1 that is encoded in the genome of Dictyostelium discoideum.


name: myosin heavy chain, non-muscle isoform 4 (fruit fly)

description: A myosin heavy chain, non-muscle (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99323-4.


name: MYO2_SCHPO Myosin type-2 heavy chain 1 (sprot)

description: A myosin type-2 heavy chain 1 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


name: myosin type-2 heavy chain 1 phosphorylated 1

description: A myosin type-2 heavy chain 1 that has been phosphorylated on a Ser residue located in the C-terminal region after the proline cluster. Example: UniProtKB:Q9USI6, Ser-1444, MOD:00046.


name: myosin heavy chain, non-muscle isoform 1 (fruit fly)

description: A myosin heavy chain, non-muscle (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99323-1.


name: myosin type-2 heavy chain 1 (Schizosaccharomyces pombe)

description: A myosin type-2 heavy chain 1 that is encoded in the genome of Schizosaccharomyces pombe.


name: MYSN_DROME Myosin heavy chain, non-muscle (sprot)

description: A myosin type-2 heavy chain 1 that is encoded in the genome of fruit fly.


name: myosin type-2 heavy chain 1 unmodified form (Schizosaccharomyces pombe)

description: A myosin type-2 heavy chain 1 unmodified form in Schizosaccharomyces pombe.


name: protein kinase C delta type phosphorylated 2 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-507 of the amino acid sequence represented by UniProtKB:Q05655. UniProtKB:Q05655, Thr-507, MOD:00047.


protein kinase C delta type

A protein kinase C, delta-like that is a translation product of the human PRKCD gene or a 1:1 ortholog thereof.


protein kinase C delta type isoform 1

A protein kinase C delta type that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q05655-1 or a 1:1 ortholog thereof.


name: protein kinase C delta type deaminated 1 (human)

description: A protein kinase C delta type (human) that has been deaminated on the residue at the position equivalent to Asn-407 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Asn-407, MOD:00684.


name: protein kinase C delta type phosphorylated 3 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-507, and phosphoserine at positions 645 and 664 of the amino acid sequence represented by UniProtKB:Q05655. UniProtKB:Q05655, Thr-507, MOD:00047|Ser-645/Ser-664, MOD:00046.


name: protein kinase C delta type isoform 1 (mouse)

description: A protein kinase C delta type isoform 1 that is encoded in the genome of mouse.


name: protein kinase C delta type phosphorylated 5 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Ser-359, MOD:00046.


name: KPCD_HUMAN Protein kinase C delta type (sprot)

description: A protein kinase C delta type that is encoded in the genome of human.


name: protein kinase C delta type methylated 2 (human)

description: A protein kinase C delta type (human) that has been methylated on the residue at the position equivalent to Cys-415 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Cys-415, MOD:00660.


name: protein kinase C delta type phosphorylated 6 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Thr-85 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Thr-85, MOD:00047.


name: protein kinase C delta type phosphorylated 1 (mouse)

description: A protein kinase C delta type (mouse) that has been phosphorylated on the residue at the position equivalent to Thr-505 of the amino acid sequence represented by UniProtKB:P28867-1. Example: UniProtKB:P28867-1, Thr-505, MOD:00047.


name: protein kinase C delta type isoform h2 (human)

description: A protein kinase C delta type (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q05655-2.


name: protein kinase C delta type phosphorylated 4 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Ser-645 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Ser-645, MOD:00046.


name: protein kinase C delta type phosphorylated 1 (human)

description: A protein kinase C delta type (human) that has been phosphorylated on the residue at the position equivalent to Tyr-155 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Tyr-155, MOD:00048.


name: KPCD_MOUSE Protein kinase C delta type (sprot)

description: A protein kinase C delta type that is encoded in the genome of mouse.


name: protein kinase C delta type isoform 2 (mouse)

description: A protein kinase C delta type isoform 2 that is encoded in the genome of mouse.


protein kinase C delta type isoform 2

A protein kinase C delta type that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28867-2 or a 1:1 ortholog thereof.


name: protein kinase C delta type methylated 1 (human)

description: A protein kinase C delta type (human) that has been methylated on the residue at the position equivalent to Cys-175 of the amino acid sequence represented by UniProtKB:Q05655-1. Example: UniProtKB:Q05655-1, Cys-175, MOD:00660.


name: protein kinase C delta type isoform 1 (human)

description: A protein kinase C delta type isoform 1 that is encoded in the genome of human.


L-TYROSINE ETHYLESTER

An L-tyrosyl ester that is L-tyrosine in which the hydrogen of the carboxy group has been replaced by an ethyl group.


protein FAM107B isoform 1 (mouse)

A protein FAM107B isoform 1 that is encoded in the genome of mouse.


name: basement membrane-specific heparan sulfate proteoglycan core protein O-glycosylated 29 (human)

description: A basement membrane-specific heparan sulfate proteoglycan core protein (human) that has been O-glycosylated at the residue equivalent to Thr-1876 of the amino acid sequence represented by UniProtKB:P98160-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P98160-1, Thr-1876, MOD:00005~GNO:G43417UB.


name: guanylate cyclase soluble subunit alpha-1 phosphorylated 1 (human)

description: A guanylate cyclase soluble subunit alpha-1 (human) that has been phosphorylated on the residue at the position equivalent to Thr-285 of the amino acid sequence represented by UniProtKB:Q02108-1. Example: UniProtKB:Q02108-1, Thr-285, MOD:00047.


name: glutamate carboxypeptidase 2 isoform r2 (rat)

description: A glutamate carboxypeptidase 2 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P70627-2.


porimin O-glycosylated 1 (human)

A porimin (human) that has been O-glycosylated at the residue equivalent to Thr-149 of the amino acid sequence represented by UniProtKB:Q8N131-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q8N131-1, Thr-149, MOD:00005~GNO:G43417UB.


PORIM_HUMAN Porimin (sprot)

A porimin that is encoded in the genome of human.


porimin isoform h2 (human)

A porimin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N131-2.


porimin isoform h1 (human)

A porimin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N131-1.


name: IAH1_YEAST Isoamyl acetate-hydrolyzing esterase (sprot)

description: An isoamyl acetate-hydrolyzing esterase 1 that is encoded in the genome of yeast.


name: TMCO2_MOUSE Transmembrane and coiled-coil domain-containing protein 2 (sprot)

description: A transmembrane and coiled-coil domain-containing protein 2 that is encoded in the genome of mouse.


name: glycine receptor subunit beta isoform 1 (mouse)

description: A glycine receptor subunit beta isoform 1 that is encoded in the genome of mouse.


name: GLRB_MOUSE Glycine receptor subunit beta (sprot)

description: A glycine receptor subunit beta that is encoded in the genome of mouse.


bryotoxin A

A bufadienolide glycoside that is 3,5,11,14-tetrahydroxy-12,19-dioxobufa-20,22-dienolide attached to a 3-O-acetyl-4,6-dideoxy-beta-D-arabino-hexopyranosyl residue at position 3 via a glycosidic linkage.


An  ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3 and 5 and a methoxy group at position 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from Aspergillus ochraceus.


A 3beta-hydroxy steroid consisting of 23,24-dimethylcholest-16-ene substituted by hydroxy groups at positions 3, 5, 6 and 20 (the 3beta,5alpha,6beta,20S stereoisomer). Isolated from the soft coral Sarcophyton trocheliophorum, it exhibits cytotoxic activity against human cancer cells.


CEREVISTEROL

An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the fungus, Xylaria species.


eurysterol B sulfonic acid

A steroid sulfate that is 5alpha-cholestane with a double bond at position 22, hydroxy groups at positions 5 and 6, a bridged oxolane between positions 8 and 19 and a sulfate group at position 3.


blazein

An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3 and 5 and a methoxy group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from the fungus, Xylaria species.


erysimoside

A cardenolide glycoside that consists of strophanthidin having a beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl moiety attached at position 3.


lucibufagin C

A defensive steroid lactone that is produced by males of the species Photinus pyralis.


helveticoside

A cardenolide glycoside that consists of strophanthidin having a digitoxosyl group attached at position 3.


globosterol

A 3beta-sterol that is 5alpha-androstane which contains a double bond between positions 7 and 8, in which the hydrogens at the 3beta, 5alpha and 6beta positions are substituted by hydroxy groups, and in which the hydrogen at the 17beta position is substituted by a (2S,3E,6xi)-6,7-dimethyloct-3-en-2-yl group. The polyhydroxylated C29 sterol was isolated from an endophytic fungus, Chaetomium globosum ZY-22; the stereochemistry at position 25 was not determined.


eurysterol A sulfonic acid

A steroid sulfate that is 5alpha-cholestane substituted by hydroxy groups at positions 5 and 6, a bridged oxolane at positions 8 and 19 pand a sulfate group at position 3.


An ergostanoid that is (22E)-ergosta-7,22-diene substituted by beta-hydroxy groups at positions 3 and 6. It has been isolated from Aspergillus ochraceus.


A 3beta-sterol that is ergosta-7,22-dien-3-ol substituted by additional hydroxy groups at positions 5, 6 and 9 (3beta,5alpha,6beta,22E stereoisomer). It has been isolated from the endophytic fungus, Chaetomium globosum.


A withanolide that is 3,6:22,26-diepoxyergost-24-ene substituted by hydroxy groups at positions 4, 5 and 27 and oxo groups at positions 1 and 26. It has been isolated from the aerial parts of Physalis longifolia.


An  ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at position 3 and 5 and an oxo group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from Aspergillus ochraceus.


An ergostanoid that is  (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 9 and an oxo group at position 6 (the 3beta,5alpha stereoisomer). It has been isolated from Aspergillus ochraceus.


dihydroouabagenin

A hexahydroxy steroidal lactone that is the 20,22-dihydro derivative of ouabagenin.


A  3beta-hydroxy steroid that is  stigmastane substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the roots of Breynia fruticosa.


A cardenolide glycoside that is strophanthidin attached to a 4,6-dideoxy-3-O-(beta-D-glucopyranosyl)-2-O-methyl-beta-D-xylo-hexopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits cytotoxic activity.


physalin D

A physalin with antimalarial and antimycobacterial activities isolated from Physalis angulata.


A dipeptide resulting from the formal condensation of the carboxy group of threonine with the amino group of cysteic acid.


name: Stage IV Primary Peritoneal Cancer AJCC v8

description: Stage IV includes: Any T, Any N, M1: M1: Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine. (from AJCC 8th Ed.)


name: Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma

description: The reemergence of platinum-resistant primary peritoneal high-grade serous adenocarcinoma after a period of remission.


name: Refractory Primary Peritoneal Endometrioid Adenocarcinoma

description: Primary peritoneal endometrioid adenocarcinoma that is resistant to treatment.


name: Refractory Primary Peritoneal Clear Cell Adenocarcinoma

description: Primary peritoneal clear cell adenocarcinoma that is resistant to treatment.


name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma

description: The reemergence of primary peritoneal clear cell adenocarcinoma after a period of remission.


name: Stage IIIB Primary Peritoneal Cancer AJCC v8

description: Stage IIIB includes: T3b, N0/N1, M0. T3b: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.)


Advanced Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that has spread extensively from its original site of growth to other anatomic sites or is no longer responding to treatment.


Clear cell adenocarcinoma of peritoneum

description: An extremely rare adenocarcinoma arising from the peritoneum. It is composed of malignant glandular epithelium containing clear cells.


name: Refractory Primary Peritoneal Transitional Cell Carcinoma

description: Primary peritoneal transitional cell carcinoma that is resistant to treatment.


name: Refractory Primary Peritoneal Adenocarcinoma

description: Primary peritoneal adenocarcinoma that is resistant to treatment.


Metastatic Primary Peritoneal Carcinoma

description: A carcinoma that arises from the peritoneum and has metastasized to another anatomic site.


name: Stage III Primary Peritoneal Cancer AJCC v7

description: Stage III includes: T3, N0, M0.  T3: Microscopically confirmed peritoneal tumor outside pelvis.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th Ed.)


name: Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma

description: Primary peritoneal high-grade serous adenocarcinoma that has spread from its original site of growth to another anatomic site.


name: Stage IIIC Primary Peritoneal Cancer AJCC v7

description: Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal tumor beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th Ed.)


name: Recurrent Primary Peritoneal Adenocarcinoma

description: The reemergence of primary peritoneal adenocarcinoma after a period of remission.


name: Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma

description: Primary peritoneal high-grade serous adenocarcinoma that is not amenable to surgical resection.


name: Refractory Primary Peritoneal Serous Adenocarcinoma

description: Primary peritoneal serous adenocarcinoma that is resistant to treatment.


name: Stage II Primary Peritoneal Cancer AJCC v8

description: Stage II includes: T2, N0, M0. T2: Primary peritoneal cancer. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


name: Metastatic Primary Peritoneal Serous Adenocarcinoma

description: Primary peritoneal serous adenocarcinoma that has spread from its original site of growth to another anatomic site.


name: Stage IIA Primary Peritoneal Cancer AJCC v8

description: Stage IIA includes: T2a, N0, M0. T2a: Primary peritoneal cancer with extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


name: Locally Advanced Unresectable Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma

description: The reemergence of primary peritoneal low grade serous adenocarcinoma after a period of remission.


name: Primary Peritoneal Transitional Cell Carcinoma

description: An extremely rare transitional cell carcinoma that arises from the peritoneum.


name: Platinum-Resistant Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that progresses between one and six months of completing platinum therapy.


name: Unresectable Primary Peritoneal Endometrioid Adenocarcinoma

description: Primary peritoneal endometrioid adenocarcinoma that is not amenable to surgical resection.


name: Primary Peritoneal Undifferentiated Carcinoma

description: An extremely rare carcinoma arising from the peritoneum. It is characterized by the presence of a diffuse malignant infiltrate that is composed of epithelial cells without evidence of glandular or squamous differentiation.


name: Unresectable Primary Peritoneal Serous Adenocarcinoma

description: Primary peritoneal serous adenocarcinoma that is not amenable to surgical resection.


name: Recurrent Primary Peritoneal Transitional Cell Carcinoma

description: The reemergence of primary peritoneal transitional cell carcinoma after a period of remission.


name: Stage IIIB Primary Peritoneal Cancer AJCC v7

description: Stage IIIB includes: T3b, N0, M0.  T3b: Macroscopic peritoneal tumor beyond pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th Ed.)


name: Metastatic Platinum-Resistant Primary Peritoneal Carcinoma

description: A platinum-resistant primary peritoneal carcinoma that has spread from its original site of growth to another anatomic site.


name: Refractory Primary Peritoneal High Grade Serous Adenocarcinoma

description: Primary peritoneal high grade serous adenocarcinoma that is resistant to treatment.


name: Recurrent Primary Peritoneal Undifferentiated Carcinoma

description: The reemergence of primary peritoneal undifferentiated carcinoma after a period of remission.


Refractory Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that is resistant to treatment.


name: Unresectable Platinum-Resistant Primary Peritoneal Carcinoma

description: A platinum-resistant primary peritoneal carcinoma that is not amenable to surgical resection.


name: Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma

description: The reemergence of platinum-sensitive primary peritoneal carcinoma after a period of remission.


name: Primary Peritoneal Cancer by AJCC v8 Stage

description: A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 8th edition.


name: Primary Peritoneal Low Grade Serous Adenocarcinoma

description: A serous adenocarcinoma that arises from the lining of the peritoneum. It is characterized by low grade histopathologic features.


name: Stage III Primary Peritoneal Cancer AJCC v8

description: Stage III includes: IIIA: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T3a: Primary peritoneal cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. T3c: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.)


name: Primary Peritoneal Cancer by AJCC v7 Stage

description: A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 7th edition.


name: Unresectable Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that is not amenable to surgical resection.


name: Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma

description: Primary peritoneal high-grade serous adenocarcinoma that progresses during platinum therapy or within one month of completing platinum therapy.


name: Primary Peritoneal Endometrioid Adenocarcinoma

description: An exceedingly rare endometrioid adenocarcinoma arising from the peritoneum.


name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

description: The reemergence of primary peritoneal high-grade serous adenocarcinoma after a period of remission.


name: Metastatic Primary Peritoneal Adenocarcinoma

description: Primary peritoneal adenocarcinoma that has spread from its original site of growth to another anatomic site.


Primary Peritoneal Adenocarcinoma

description: A rare adenocarcinoma that arises from the lining of the peritoneum.


name: Stage IV Primary Peritoneal Cancer AJCC v7

description: Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 7th Ed.)


name: Platinum-Refractory Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that progresses during platinum therapy or within one month of completing platinum therapy.


name: Unresectable Primary Peritoneal Adenocarcinoma

description: Primary peritoneal adenocarcinoma that is not amenable to surgical resection.


name: Stage IVA Primary Peritoneal Cancer AJCC v8

description: Stage IVA includes: Any T, Any N, M1a. M1a: Primary peritoneal cancer with pleural effusion with positive cytology. (from AJCC 8th Ed.)


name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma

description: The reemergence of primary peritoneal endometrioid adenocarcinoma after a period of remission.


Recurrent Primary Peritoneal Carcinoma

description: The reemergence of primary peritoneal carcinoma after a period of remission.


name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma

description: The reemergence of platinum-resistant primary peritoneal carcinoma after a period of remission.


name: Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma

description: Primary peritoneal low grade serous adenocarcinoma that is resistant to treatment.


name: Stage IIIA Primary Peritoneal Cancer AJCC v7

description: Stage IIIA includes: T3a, N0, M0.  T3a: Microscopic peritoneal tumor beyond pelvis (no macroscopic tumor). N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th Ed.)


name: Refractory Primary Peritoneal Undifferentiated Carcinoma

description: Primary peritoneal undifferentiated carcinoma that is resistant to treatment.


name: Locally Advanced Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Stage IIIC Primary Peritoneal Cancer AJCC v8

description: Stage IIIC includes: T3c, N0/N1, M0. T3c: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.)


name: Stage IIIA Primary Peritoneal Cancer AJCC v8

description: Stage IIIA includes: T3a, N0/N1, M0. T3a: Primary peritoneal cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.)


name: Recurrent Primary Peritoneal Serous Adenocarcinoma

description: The reemergence of primary peritoneal serous adenocarcinoma after a period of remission.


name: Stage IIB Primary Peritoneal Cancer AJCC v8

description: Stage IIB includes: T2b, N0, M0. T2b: Primary peritoneal cancer with tumor extension to and/or implants on other pelvic tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


name: Stage IVB Primary Peritoneal Cancer AJCC v8

description: Stage IVB includes: Any T, Any N, M1b. M1b: Primary peritoneal cancer with liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine. (from AJCC 8th Ed.)


name: Primary Peritoneal High Grade Serous Adenocarcinoma

description: A serous adenocarcinoma that arises from the lining of the peritoneum. It is characterized by high grade histopathologic features.


name: Platinum-Sensitive Primary Peritoneal Carcinoma

description: Primary peritoneal carcinoma that has a documented response to platinum-based chemotherapy.


name: Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma

description: Primary peritoneal high-grade serous adenocarcinoma that progresses between one and six months of completing platinum therapy.


name: protein FAM50A, initiator methionine removed form (human)

description: A protein FAM50A (human) that has had the initiator methionine removed. UniProtKB:Q14320, 2-339.


name: CALML_DICDI Calmodulin-like protein (sprot)

description: A protein that is a translation product of the calB gene in Dictyostelium discoideum.


name: PMIS2_MOUSE Transmembrane protein PMIS2 (sprot)

description: A protein that is a translation product of the Pmis2 gene in mouse.


name: ATP-binding cassette sub-family A member 2 isoform h4 (human)

description: An ATP-binding cassette sub-family A member 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BZC7-4.


name: ORP4C_ARATH Oxysterol-binding protein-related protein 4C (sprot)

description: A protein that is a translation product of the ORP4C gene in Arabidopsis thaliana.


protein dhs-3 isoform b (worm)

A protein dhs-3 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A5JYX5-1.


M1_I51A0 Matrix protein 1 (sprot)

An influenzavirus matrix protein 1 that is encoded in the genome of the H1N1 strain A/USA:Albany/12/1951.


name: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 isoform 1 (rat)

description: A 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 isoform 1 that is encoded in the genome of rat.


name: F261_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (sprot)

description: A 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 that is encoded in the genome of rat.


name: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 isoform r2 (rat)

description: A 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P07953-2.


name: PHD finger-like domain-containing protein 5A isoform 1

description: A PHD finger-like domain-containing protein 5A that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7RTV0-1 or a 1:1 ortholog thereof.


name: PHD finger-like domain-containing protein 5A isoform 1 (human)

description: A PHD finger-like domain-containing protein 5A isoform 1 that is encoded in the genome of human.


name: PHD finger-like domain-containing protein 5A isoform 1 (mouse)

description: A PHD finger-like domain-containing protein 5A isoform 1 that is encoded in the genome of mouse.


name: PHD finger-like domain-containing protein 5A isoform 1 (rat)

description: A PHD finger-like domain-containing protein 5A isoform 1 that is encoded in the genome of rat.


name: CD99 antigen-like protein 2 isoform 2 (zebrafish)

description: A CD99 antigen-like protein 2 (zebrafish) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6DBW9-2.


name: primary microcephaly-mild intellectual disability-young-onset diabetes syndrome


name: SH3-containing GRB2-like protein 3-interacting protein 1 isoform m3 (mouse)

description: An SH3-containing GRB2-like protein 3-interacting protein 1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8VD37-3.


name: CCR4D_ARATH Carbon catabolite repressor protein 4 homolog 4 (sprot)

description: A nocturnin that is encoded in the genome of Arabidopsis thaliana.


name: carbon catabolite repressor protein 4 homolog 4 isoform 3 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-3.


name: carbon catabolite repressor protein 4 homolog 4 isoform 4 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-4.


name: carbon catabolite repressor protein 4 homolog 4 isoform 5 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-5.


name: carbon catabolite repressor protein 4 homolog 4 isoform 1 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-1.


name: carbon catabolite repressor protein 4 homolog 4 isoform 6 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-6.


name: carbon catabolite repressor protein 4 homolog 4 isoform 2 (Arabidopsis thaliana)

description: A carbon catabolite repressor protein 4 homolog 4 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MS41-2.


name: copper transport protein ATOX1 methylated 1 (human)

description: A copper transport protein ATOX1 (human) that has been methylated on the residue at the position equivalent to Cys-41 of the amino acid sequence represented by UniProtKB:O00244. UniProtKB:O00244, Cys-41, MOD:00660.


copper transport protein ATOX1

A protein that is a translation product of the human ATOX1 gene or a 1:1 ortholog thereof.


name: ATOX1_HUMAN Copper transport protein ATOX1 (sprot)

description: A copper transport protein ATOX1 that is encoded in the genome of human.


name: ATOX1_MOUSE Copper transport protein ATOX1 (sprot)

description: A copper transport protein ATOX1 that is encoded in the genome of mouse.


name: copper transport protein ATOX1 cysteinylated 1 (human)

description: A copper transport protein ATOX1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-15 of the amino acid sequence represented by UniProtKB:O00244. UniProtKB:O00244, Cys-15, MOD:00765.


name: copper transport protein ATOX1, initiator methionine removed form

description: A copper transport protein ATOX1 that has had the initiator methionine removed.


name: copper transport protein ATOX1 isoform 1

description: A copper transport protein ATOX1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00244-1 or a 1:1 ortholog thereof.


name: ATOX1_DICDI Copper transport protein ATOX1 homolog (sprot)

description: A copper transport protein ATOX1 that is encoded in the genome of Dictyostelium discoideum.


name: copper transport protein ATOX1 isoform 1 (mouse)

description: A copper transport protein ATOX1 isoform 1 that is encoded in the genome of mouse.


name: copper transport protein ATOX1, initiator methionine removed form (mouse)

description: A copper transport protein ATOX1, initiator methionine removed form in mouse. UniProtKB:O08997, 2-68.


name: ATOX1_RAT Copper transport protein ATOX1 (sprot)

description: A copper transport protein ATOX1 that is encoded in the genome of rat.


name: copper transport protein ATOX1 isoform 1 (human)

description: A copper transport protein ATOX1 isoform 1 that is encoded in the genome of human.


name: copper transport protein ATOX1 isoform 1 (rat)

description: A copper transport protein ATOX1 isoform 1 that is encoded in the genome of rat.


leprosy, susceptibility to, 5

description: Any leprosy in which the cause of the disease is a mutation in the TLR1 gene.


name: OGFR_RAT Opioid growth factor receptor (sprot)

description: An opioid growth factor receptor that is encoded in the genome of rat.


Grade 4 Tricuspid Valve Disease, CTCAE

description: Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)


Tricuspid Valve Disease, CTCAE

description: A disorder characterized by a defect in tricuspid valve function or structure.


Grade 5 Tricuspid Valve Disease, CTCAE

description: Death


Grade 2 Tricuspid Valve Disease, CTCAE

description: Asymptomatic; moderate regurgitation or stenosis by imaging


Grade 3 Tricuspid Valve Disease, CTCAE

description: Symptomatic; severe regurgitation or stenosis; symptoms controlled with medical intervention


Grade 1 Tricuspid Valve Disease, CTCAE

description: Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis


DnaJ homolog dnj-5 isoform A (worm)

A DnaJ homolog dnj-5 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q09446-1.


name: INSC6_ECOLI Transposase InsC for insertion element IS2K (sprot)

description: A protein that is a translation product of the insC6 gene in Escherichia coli K-12.


name: DNA-directed RNA polymerase III subunit RPC4 isoform 1 (mouse)

description: A DNA-directed RNA polymerase III subunit RPC4 isoform 1 that is encoded in the genome of mouse.


vascular cancer

description: A malignant neoplasm arising from the blood vessels.


great vessel cancer

description: A malignant neoplasm arising from the great vessels.


Malignant Inferior Vena Cava Neoplasm

description: A malignant neoplasm involving the inferior vena cava.


pulmonary artery choriocarcinoma

description: A rare choriocarcinoma that arises from a pulmonary artery.


Malignant Superior Vena Cava Neoplasm

description: A malignant neoplasm involving the superior vena cava.


superior vena cava leiomyosarcoma

description: An aggressive malignant smooth muscle neoplasm, arising from the superior vena cava. It is characterized by a proliferation of neoplastic spindle cells.


Benign neoplasm of great vessels

description: A neoplasm that arises from the great vessels and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


aortic malignant tumor

description: A cancer that involves the aorta.


name: PTQA_ECOLI PTS system N,N'-diacetylchitobiose-specific EIIA component (sprot)

description: A PTS system N,N'-diacetylchitobiose-specific EIIA component that is encoded in the genome of Escherichia coli K-12.


name: PTS system N,N'-diacetylchitobiose-specific EIIA component

description: A protein that is a translation product of the Escherichia coli K-12 chbA gene or a 1:1 ortholog thereof.


YUKE_BACSU Protein YukE (sprot)

A protein that is a translation product of the yukE gene in Bacillus subtilis subsp. subtilis str. 168.


name: TM267_HUMAN Transmembrane protein 267 (sprot)

description: A transmembrane protein 267 that is encoded in the genome of human.


scleroderma, chicken

description: Scleroderma that occurs in chicken.


name: 2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-producing] [NADPH], initiator methionine removed form

description: A 2,4-dienoyl-CoA reductase [(2E)-enoyl-CoA-producing] that has had the initiator methionine removed.


name: sentrin-specific protease 2 isoform 2 (mouse)

description: A sentrin-specific protease 2 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q91ZX6-2.


BENZOXABOROLE

A member of the class of benzoxaboroles that is 2,1-benzoxaborole in which the hydrogen attached to the boron atom is replaced by a hydroxy group.


fusoxypene B

A pentacyclic sesterterpene derivative.


name: Uterine Corpus Carcinoma and Carcinosarcoma pT1 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor confined to the corpus uteri, including endocervical glandular involvement. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma TNM Finding v8

description: A finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system. This classification system does not apply to uterine corpus sarcomas: leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas. These sarcomas are staged according to the classification for uterine corpus sarcomas. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Clinical TNM Finding v8

description: A clinical finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system.


name: Uterine Corpus Carcinoma and Carcinosarcoma pN1 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis to pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT1b TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor invading one half or more of the myometrium. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pN1mi TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis (greater than 0.2 mm but nor greater than 2.0 mm in diameter) to pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT3 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor involving serosa, adnexa, vagina, or parametrium. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT3a TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor involving the serosa and/or adnexa (direct extension or metastasis). (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pM1 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone. It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa). (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pN0(i+) TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with isolated tumor cells in regional lymph node(s) no greater than 0.2 mm. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Clinical Distant Metastasis TNM Finding v8

description: A clinical finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.


name: Uterine Corpus Carcinoma and Carcinosarcoma pN2mi TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis (greater than 0.2 mm but not greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT0 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with no evidence of primary tumor. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT1a TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor limited to the endometrium or invading less than half the myometrium. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Primary Tumor TNM Finding v8

description: A pathologic finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor. The definitions of the T categories correspond to the stages accepted by FIGO. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT4 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor invading the bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Pathologic TNM Finding v8

description: A pathologic finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system.


name: Uterine Corpus Carcinoma and Carcinosarcoma pN2 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma cM0 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma without evidence of distant metastasis. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Regional Lymph Nodes TNM Finding v8

description: A pathologic finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.


name: Uterine Corpus Carcinoma and Carcinosarcoma pN0 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with no regional lymph node metastasis. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT2 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does not include endocervical glandular involvement. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pN1a TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis (greater than 2.0 mm in diameter) to pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pN2a TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with regional lymph node metastasis (greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pT3b TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with vaginal involvement (direct extension or metastasis) or parametrial involvement. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Distant Metastasis TNM Finding v8

description: A pathologic finding about one or more characteristics of uterine corpus carcinoma or carcinosarcoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.


name: Uterine Corpus Carcinoma and Carcinosarcoma cM1 TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma with distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone. It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa). (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pTX TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)


name: Uterine Corpus Carcinoma and Carcinosarcoma pNX TNM Finding v8

description: Uterine corpus carcinoma or carcinosarcoma in which the regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)


name: 5'-AMP-activated protein kinase catalytic subunit alpha-2 isoform b (worm)

description: A 5'-AMP-activated protein kinase catalytic subunit alpha-2 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q95ZQ4-1.


name: putative uncharacterized protein encoded by FER1L6-AS2

description: A protein that is a translation product of the human FER1L6-AS2 gene or a 1:1 ortholog thereof.


name: FEAS2_HUMAN Putative uncharacterized protein encoded by FER1L6-AS2 (sprot)

description: A putative uncharacterized protein encoded by FER1L6-AS2 that is encoded in the genome of human.


A naphthalenecarboxamide resulting from the formal condensation of the carboxy group of 2-naphthoic acid with ammonia.


farnesol

A farnesane sesquiterpenoid that is dodeca-2,6,10-triene substituted by methyl groups at positions 3, 7 and 11 and a hydroxy group at position 1.


The (2E,6Z)-stereoisomer of farnesol.


leukosialin O-glycosylated 84 (human)

A leukosialin (human) that has been O-glycosylated at the residue equivalent to Thr-136 of the amino acid sequence represented by UniProtKB:P16150-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P16150-1, Thr-136, MOD:00005~GNO:G65562ZE.


name: immunoglobulin heavy constant mu N-glycosylated 96 (human)

description: An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-46 of the amino acid sequence represented by UniProtKB:P01871-2, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P01871-2, Asn-46, MOD:00160~GNO:G12580WI.


name: mitochondrial intermembrane space import and assembly protein 40 isoform 1 (mouse)

description: A mitochondrial intermembrane space import and assembly protein 40 isoform 1 that is encoded in the genome of mouse.


name: cytochrome c oxidase subunit 8B, mitochondrial isoform 1

description: A cytochrome c oxidase subunit 8B, mitochondrial that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48772-1 or a 1:1 ortholog thereof.


name: cytochrome c oxidase subunit 8B, mitochondrial

description: A protein that is a translation product of the mouse Cox8b gene or a 1:1 ortholog thereof.


name: COX8B_RAT Cytochrome c oxidase subunit 8B, mitochondrial (sprot)

description: A cytochrome c oxidase subunit 8B, mitochondrial that is encoded in the genome of rat.


name: COX8B_MOUSE Cytochrome c oxidase subunit 8B, mitochondrial (sprot)

description: A cytochrome c oxidase subunit 8B, mitochondrial that is encoded in the genome of mouse.


name: cytochrome c oxidase subunit 8B, mitochondrial isoform 1 (rat)

description: A cytochrome c oxidase subunit 8B, mitochondrial isoform 1 that is encoded in the genome of rat.


name: cytochrome c oxidase subunit 8B, mitochondrial isoform 1 (mouse)

description: A cytochrome c oxidase subunit 8B, mitochondrial isoform 1 that is encoded in the genome of mouse.


name: autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction


name: peptidyl-prolyl cis-trans isomerase FKBP14 isoform 1 (human)

description: A peptidyl-prolyl cis-trans isomerase FKBP14 isoform 1 that is encoded in the genome of human.


name: NGFI-A-binding protein 2 isoform 1 (human)

description: An NGFI-A-binding protein 2 isoform 1 that is encoded in the genome of human.


Metastatic Malignant Glomus Tumor

description: A malignant glomus tumor that has spread from its original site of growth to another anatomic site.


Locally Advanced Malignant Glomus Tumor

description: A malignant glomus tumor that has spread from its original site of growth to nearby tissues or lymph nodes.


Unresectable Malignant Glomus Tumor

description: A malignant glomus tumor that is not amenable to surgical resection.


Refractory Malignant Glomus Tumor

description: A malignant glomus tumor that is resistant to treatment.


Decreased Pigmentation

description: Decrease in the amount of pigment.


Scleral Disorder, CTCAE

description: A disorder characterized by involvement of the sclera of the eye.


Grade 3 Scleral Disorder, CTCAE

description: Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL


Grade 4 Scleral Disorder, CTCAE

description: Best corrected visual acuity of 20/200 or worse in the affected eye


Grade 1 Scleral Disorder, CTCAE

description: No change in vision from baseline


Grade 2 Scleral Disorder, CTCAE

description: Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL


Penile Cancer cM0 TNM Finding v7

description: Penile cancer without evidence of distant metastasis. (from AJCC 7th Ed.)


A C-nitro compound in which the nitro group is substituted into the 4-position of benzohydrazide.


Stage III Fallopian Tube Cancer AJCC v6

description: Stage III includes: (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c, N0, M0).  T3: Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis.  T3a: Microscopic peritoneal metastasis outside the pelvis.  T3b: Macroscopic peritoneal metastasis outside the pelvis 2cm or less in greatest dimension.  T3c: Peritoneal metastasis more than 2cm in diameter. (AJCC 6th ed.)


name: tumor necrosis factor receptor superfamily member 6 isoform 6

description: A tumor necrosis factor receptor superfamily member 6 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P25445-6 or a 1:1 ortholog thereof.


name: tumor necrosis factor receptor superfamily member 6 isoform 6 (human)

description: A tumor necrosis factor receptor superfamily member 6 isoform 6 that is encoded in the genome of human.


A 7-deazaguanine ribonucleoside that is queuosine having a alpha-D-mannosyl residue attached at position 4''.


alpha-D-mannoside

Any mannoside in which the anomeric centre has alpha-configuration.


A disaccharide that is D-galactose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-mannopyranoside.


An alpha-D-glucoside that is (27R)-1,27-dihydroxyoctacosan-3-one on which the hydroxyl hydrogen at position 1 has been replaced by an alpha-D-mannosyl residue.


A polysaccharide composed of alpha-D-mannose joined by a (1->4)-linkage to a poly[3-O-methyl-alpha-D-mannosyl] group which is further linked to a 1-O,3-O-dimethyl-alpha-D-mannose via a (1->4)-linkage.


Any alpha-D-mannoside derived from 6-phospho-alpha-D-mannose.


An indolyl carbohydrate that is the alpha-D-mannoside of indoxyl in which the indole moiety is substituted at positions 4 and 5 by chlorine and bromine, respectively


p-aminophenyl alpha-D-mannoside

An alpha-D-mannoside having 4-aminophenyl as the anomeric substituent.


Any alpha-D-mannoside derived from 2,4-di-O-phospho-alpha-D-mannose


Any alpha-D-mannoside derived from 6-(alpha-D-glucose-1-phospho)-alpha-D-mannose.


Any alpha-D-mannoside derived from 6-(N-acetyl-alpha-D-glucosaminyl-1-phospho)-alpha-D-mannose.


methyl alpha-D-mannoside

A methyl mannoside having alpha-configuration at the anomeric centre.


An alpha-D-Manp-(1->2)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


name: C71BD_ARATH Cytochrome P450 71B13 (sprot)

description: A protein that is a translation product of the CYP71B13 gene in Arabidopsis thaliana.


name: uncharacterized protein C4orf3 isoform h2 (human)

description: An uncharacterized protein C4orf3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WVX3-2.


name: CD003_HUMAN Uncharacterized protein C4orf3 (sprot)

description: An uncharacterized protein C4orf3 that is encoded in the genome of human.


name: uncharacterized protein C4orf3 isoform h1 (human)

description: An uncharacterized protein C4orf3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WVX3-1.


name: AXR4_ARATH Protein AUXIN RESPONSE 4 (sprot)

description: A protein that is a translation product of the AXR4 gene in Arabidopsis thaliana.


name: YDDM_ECOLI Uncharacterized HTH-type transcriptional regulator YddM (sprot)

description: An uncharacterized HTH-type transcriptional regulator YddM that is encoded in the genome of Escherichia coli K-12.


name: olfactory receptor 6A2 isoform 1 (human)

description: An olfactory receptor 6A2 isoform 1 that is encoded in the genome of human.


olfactory receptor 6A2 isoform 1

An olfactory receptor 6A2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95222-1 or a 1:1 ortholog thereof.


olfactory receptor 226 isoform 1 (rat)

An olfactory receptor 6A2 isoform 1 that is encoded in the genome of rat.


Grade 2 Anal Fissure, CTCAE

description: Symptomatic


Anal Fissure, CTCAE

description: A disorder characterized by a tear in the lining of the anus.


Grade 1 Anal Fissure, CTCAE

description: Asymptomatic


Grade 3 Anal Fissure, CTCAE

description: Invasive intervention indicated


name: intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome


DNA ligase 1 isoform h2 (human)

A DNA ligase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18858-2.


A member of the class of phenanthrolines that is 4,7-diphenyl-1,10-phenanthroline carrying two additional sulfo substituents at positions 4' and 4''


YAFZ_ECOLI UPF0380 protein YafZ (sprot)

A UPF0380 protein YafZ that is encoded in the genome of Escherichia coli K-12.


Stage IA2 Lung Cancer AJCC v8

description: Stage IA2 includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.)


name: intercellular adhesion molecule 4, signal peptide removed form (human)

description: An intercellular adhesion molecule 4 (human) that has had the signal peptide removed. UniProtKB:Q14773, 23-271.


name: Y3210_ARATH BTB/POZ domain-containing protein At3g22104 (sprot)

description: A protein that is a translation product of the At3g22104 gene in Arabidopsis thaliana.


name: tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform 1 (mouse)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform 1 that is encoded in the genome of mouse.


name: OSGL1_MOUSE tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (sprot)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial that is encoded in the genome of mouse.


name: tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform m2 (mouse)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6PEB4-2.


name: B-cell linker protein isoform h3 (human)

description: A B-cell linker protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WV28-3.


name: BRCA1-associated RING domain protein 1 isoform beta (human)

description: A BRCA1-associated RING domain protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99728-3.


name: alpha-aminoadipic semialdehyde synthase isoform Short (Arabidopsis thaliana)

description: An alpha-aminoadipic semialdehyde synthase (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9SMZ4-2.


A member of the class of  chromenes that is 2H-1-benzopyran-7-ol acetate substituted by methyl groups at positions 2 and 2, an ethyl group at position 4 and a 4-methoxyphenyl group at position 3 respectively.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 isoform h2 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BRP7-2.


name: FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 (sprot)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 that is encoded in the genome of human.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 phosphorylated 1 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that has been phosphorylated on the residue at the position equivalent to Ser-476 of the amino acid sequence represented by UniProtKB:Q9BRP7-1. Example: UniProtKB:Q9BRP7-1, Ser-476, MOD:00046.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 isoform h1 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BRP7-1.


name: CSU2_ARATH Protein COP1 SUPPRESSOR 2 (sprot)

description: A splicing factor C9orf78 that is encoded in the genome of Arabidopsis thaliana.


name: regulatory protein SWI6 phosphorylated 1 (yeast)

description: A regulatory protein SWI6 (yeast) that has been phosphorylated at Ser-238. UniProtKB:P09959, Ser-238, MOD:00046.


name: SWI6_YEAST Regulatory protein SWI6 (sprot)

description: A protein that is a translation product of the SWI6 gene in yeast.


malectin isoform 1 (rat)

A malectin isoform 1 that is encoded in the genome of rat.


name: YKQA_CAEEL Uncharacterized protein C06E1.11 (sprot)

description: A protein that is a translation product of the C06E1.11 gene in worm.


name: X-ray repair cross-complementing protein 5 cysteinylated 2 (human)

description: An X-ray repair cross-complementing protein 5 (human) that has been cysteinylated on the residue at the position equivalent to Cys-493 of the amino acid sequence represented by UniProtKB:P13010. UniProtKB:P13010, Cys-493, MOD:00765.


name: ocular dysgenesis caused by defects in PAX6 regulation

description: Any eye disorder in which the cause of the disease is a variant in the PAX6 gene itself or a variant within another locus that results in defective regulation of the PAX6 gene.


name: histone deacetylase 11 cysteinylated 1 (mouse)

description: A histone deacetylase 11 (mouse) that has been cysteinylated on the residue at the position equivalent to Cys-331 of the amino acid sequence represented by UniProtKB:Q91WA3. UniProtKB:Q91WA3, Cys-331, MOD:00765.


name: multidrug and toxin extrusion protein 1 isoform h2 (human)

description: A multidrug and toxin extrusion protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96FL8-2.


name: Melanoma of the Conjunctiva cT2a TNM Finding v7

description: Melanoma of the nonbulbar (palpebral, forniceal, but no caruncular) conjunctiva less than or equal to 1 quadrant.  (from AJCC 7th Ed.)


name: Metastatic malignant neoplasm to prostate

description: The spread of a malignant neoplasm to the prostate gland from an adjacent or distant anatomic site.


name: Metastatic Malignant Neoplasm in the Male Reproductive System

description: The spread of a malignant neoplasm to the male reproductive system from an adjacent or distant anatomic site.


Secondary Prostate Urothelial Carcinoma

description: A transitional cell carcinoma that has spread to the prostate gland directly from the bladder.


name: Metastatic malignant neoplasm to seminal vesicle

description: The spread of a malignant neoplasm to the seminal vesicle from an adjacent or distant anatomic site.


Metastatic malignant neoplasm to testis

description: A malignant neoplasm that has spread to the testis from another anatomic site.


name: Metastatic malignant neoplasm to epididymis

description: A malignant neoplasm that has metastasized to the epididymis from another anatomic site.


Metastatic malignant neoplasm to penis

description: The spread of a malignant neoplasm to the penis from an adjacent or distant anatomic site.


name: F-box/LRR-repeat protein 4 isoform 1 (mouse)

description: An F-box/LRR-repeat protein 4 isoform 1 that is encoded in the genome of mouse.


F-box/LRR-repeat protein 4 isoform 1

An F-box/LRR-repeat protein 4 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKA2-1 or a 1:1 ortholog thereof.


name: F-box/LRR-repeat protein 4 isoform 1 (human)

description: An F-box/LRR-repeat protein 4 isoform 1 that is encoded in the genome of human.


name: autism susceptibility gene 2 protein homolog isoform m3 (mouse)

description: An autism susceptibility gene 2 protein homolog (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A0A087WPF7-3.


name: Grade 4 Neck Infection NOS with Unknown Absolute Neutrophil Count, CTCAE


name: Grade 1 Peritoneal Cavity Intra-Operative Injury, CTCAE


name: electrogenic sodium bicarbonate cotransporter 1 sequence variant G427L (human)

description: An electrogenic sodium bicarbonate cotransporter 1 (human) that has a Leu residue at the position equivalent to Gly-427 of the amino acid sequence represented by UniProtKB:Q9Y6R1-1. Example: UniProtKB:Q9Y6R1-1, Gly-427, CHEBI:30006.


ELOB_MOUSE Elongin-B (sprot)

An elongin-B that is encoded in the genome of mouse.


elongin-B isoform 1 (mouse)

An elongin-B isoform 1 that is encoded in the genome of mouse.


name: TRIML_HUMAN Probable E3 ubiquitin-protein ligase TRIML1 (sprot)

description: A probable E3 ubiquitin-protein ligase TRIML1 that is encoded in the genome of human.


name: probable E3 ubiquitin-protein ligase TRIML1

description: A protein that is a translation product of the human TRIML1 gene or a 1:1 ortholog thereof.


name: TRIML_MOUSE Probable E3 ubiquitin-protein ligase TRIML1 (sprot)

description: A probable E3 ubiquitin-protein ligase TRIML1 that is encoded in the genome of mouse.


name: TXD11_MOUSE Thioredoxin domain-containing protein 11 (sprot)

description: A thioredoxin domain-containing protein 11 that is encoded in the genome of mouse.


name: thioredoxin domain-containing protein 11 isoform m1 (mouse)

description: A thioredoxin domain-containing protein 11 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K2W3-1.


name: thioredoxin domain-containing protein 11 isoform m2 (mouse)

description: A thioredoxin domain-containing protein 11 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K2W3-2.


name: E3 ubiquitin-protein ligase DTX3L cysteinylated 1 (human)

description: An E3 ubiquitin-protein ligase DTX3L (human) that has been cysteinylated on the residue at the position equivalent to Cys-577 of the amino acid sequence represented by UniProtKB:Q8TDB6-1. Example: UniProtKB:Q8TDB6-1, Cys-577, MOD:00765.


name: Merkel Cell Carcinoma cM1a TNM Finding v7

description: Merkel cell carcinoma with metastasis to skin, subcutaneous tissues or distant lymph nodes.  (from AJCC 7th Ed.)


name: Merkel Cell Carcinoma cM1 TNM Finding v7

description: Merkel cell carcinoma with metastasis beyond regional lymph nodes. (from AJCC 7th Ed.)


name: Merkel Cell Carcinoma cM1b TNM Finding v7

description: Merkel cell carcinoma with metastasis to lung. (from AJCC 7th Ed.)


name: Merkel Cell Carcinoma cM1c TNM Finding v7

description: Merkel cell carcinoma with metastasis to all other visceral sites. (from AJCC 7th Ed.)


O-hexadecanedioyl-L-carnitine

An O-acyl-L-carnitine in which the acyl group is specified as hexadecanedioyl.


Edentulous

description: An indication that an individual lacks teeth/dentition.


VOME_MOUSE Vomeromodulin (sprot)

A protein that is a translation product of the Bpifb9a gene in mouse.


vomeromodulin isoform m2 (mouse)

A vomeromodulin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q80XI7-2.


vomeromodulin isoform m1 (mouse)

A vomeromodulin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q80XI7-1.


ORML3_DANRE ORM1-like protein 3 (sprot)

An ORM1-like protein 3 that is encoded in the genome of zebrafish.


name: ORM1-like protein 3 isoform 1 (zebrafish)

description: An ORM1-like protein 3 isoform 1 that is encoded in the genome of zebrafish.


JARD2_DANRE Protein Jumonji (sprot)

A protein Jumonji that is encoded in the genome of zebrafish.


name: PTN1_HUMAN Tyrosine-protein phosphatase non-receptor type 1 (sprot)

description: A tyrosine-protein phosphatase non-receptor type 1 that is encoded in the genome of human.


name: tyrosine-protein phosphatase non-receptor type 1 methylated 2 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-121 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-121, MOD:00660.


name: tyrosine-protein phosphatase non-receptor type 1 phosphorylated 1 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been phosphorylated at Tyr-66. UniProtKB:P18031, Tyr-66, MOD:00048.


name: tyrosine-protein phosphatase non-receptor type 1 methylated 1 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-426 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-426, MOD:00660.


name: elongation factor G isoform 1 (Escherichia coli K-12)

description: An elongation factor G isoform 1 that is encoded in the genome of Escherichia coli K-12.


elongation factor G isoform 1

An elongation factor G that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P0A6M8-1 or a 1:1 ortholog thereof.


name: elongation factor G isoform 1, initiator methionine removed form (Escherichia coli K-12)

description: An elongation factor G isoform 1, initiator methionine removed form in Escherichia coli K-12. UniProtKB:P0A6M8-1, 2-704.


name: elongation factor G isoform 1, initiator methionine removed acetylated 1 (Escherichia coli K-12)

description: An elongation factor G isoform 1, initiator methionine removed acetylated 1 in Escherichia coli K-12. UniProtKB:P0A6M8-1, 2-704, Lys-504/Lys-643, MOD:00064.


name: elongation factor G isoform 1, initiator methionine removed form

description: An elongation factor G isoform 1 that has had the initiator methionine removed.


name: elongation factor G isoform 1, initiator methionine removed acetylated 1

description: An elongation factor G isoform 1, initiator methionine removed form that has been post-translationally modified to include N6-acetyllysine residues. Example: UniProtKB:P0A6M8-1, 2-704, Lys-504/Lys-643, MOD:00064.


name: FUCO_MOUSE Tissue alpha-L-fucosidase (sprot)

description: A tissue alpha-L-fucosidase that is encoded in the genome of mouse.


name: fibroblast growth factor receptor-like 1 isoform 2 (rat)

description: A fibroblast growth factor receptor-like 1 isoform 2 that is encoded in the genome of rat.


name: SMIM1_MOUSE Small integral membrane protein 1 (sprot)

description: A small integral membrane protein 1 that is encoded in the genome of mouse.


description: A cholangiocarcinoma that has developed following infection with Opisthorchis viverrini.


name: Stage 0 Hilar Cholangiocarcinoma AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ/high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Locally Advanced Distal Bile Duct Carcinoma

description: Distal bile duct carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage IVB includes: Any T, Any N, M1.  M1: Distant metastasis. (from AJCC 7th Ed.)